Physician profile
Ashley Abraham
NPI 1457615742
$1,005.92
in general payments reported to CMS, 2019-2025
19 companies · $122 in 2025
The $122 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $92.76 · 2020: $72.04 · 2021: $283 · 2022: $118 · 2023: $69.60 · 2024: $249 · 2025: $122.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $440.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $440.13 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $266.50 | 2019-2024 | |
| Hologic Sales and Service, LLC | $120.51 | 2019-2025 | Myosure Tissue Removal Device, Acessa Provu System, Sonata Sonography-Guided Transcervical Fibroid Ablation System |
| Sumitomo Pharma America, INC. | $108.22 | 2023-2025 | Myfembree, Gemtesa |
| Aspira Women'S Health INC | $75.00 | 2021 | |
| Amgen INC. | $67.05 | 2020-2024 | |
| Organon LLC | $60.99 | 2021-2025 | Nexplanon |
| Pfizer INC. | $56.63 | 2020-2024 | |
| Myovant Sciences INC. | $28.94 | 2022 | |
| Coopersurgical, INC. | $28.43 | 2021-2024 | Paragard T 380a |
| Dysis Medical, INC. | $27.94 | 2020 | |
| Biogen, INC. | $23.04 | 2024 | Zurzuvae |
| Avanos Medical | $23.01 | 2023 | On-Q* Pump and Accessories |
| Agile Therapeutics, INC. | $22.91 | 2022 | |
| Therapeuticsmd, INC. | $18.81 | 2022 | |
| Mayne Pharma Commercial LLC | $18.49 | 2021 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ibsa Pharma INC. | $17.91 | 2023 | Tirosint, Licart |
| Exeltis, USA INC. | $15.18 | 2025 | Slynd |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $14.41 | 2024 | Trulance, Xifaxan |
| Allergan, INC. | $11.95 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ashley Abraham listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.